General cellular proliferation

General cellular proliferation refers to the physiological process by which cells increase their population through the coordinated phases of the cell cycle, including DNA replication and mitosis [1]. It is a fundamental mechanism essential for embryonic development, organogenesis, and the maintenance of tissue homeostasis in adults [2]. In a clinical context, 'general cellular proliferation' is not a specific molecular target but a complex biological process that is frequently dysregulated in diseases such as cancer, where cells bypass normal growth checkpoints [3]. Pharmacological intervention typically involves the use of antineoplastic agents that target various stages of the cell cycle to induce arrest or apoptosis [4]. These agents include cytotoxic chemotherapies that damage DNA or disrupt the mitotic spindle, as well as targeted therapies that inhibit specific signaling nodes like CDK4/6 or mTOR [4]. Because proliferation is also a requirement for the function of healthy tissues, such as the hematopoietic system and intestinal lining, drugs that inhibit this process often present significant safety concerns, including myelosuppression and gastrointestinal distress [5].

Other names

Cell proliferationCellular growthCell divisionMitotic activityCellular multiplication

Inhibition of DNA synthesis, disruption of microtubule assembly, or blockade of cyclin-dependent kinases to arrest the cell cycle and prevent division.